Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Biosimilars Versus Generics: Differences in the Regulatory Review Process
Ashley Mains Espinosa, PharmD, Director of System Pharmacy Business Services at SCL Health, discusses the regulatory review process for biosimilars and how it differs from the generic approval process.
At the American Society for Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition, Ashley Mains Espinosa, PharmD, Director of System Pharmacy Business Services at SCL Health, discussed the regulatory review process for biosimilars and how it differs from the generic review process.
Recent Videos
Related Content
